| ?? |
?? ?? |
CAS |
MF |
 |
L-Aspartic acid, L-lysyl-L-α-glutamyl- |
204271-66-9 |
C15H26N4O8 |
 |
ATF4 |
|
|
![5-[(4-??????-3,5-????-??)??]????-2,4-???](/CAS/GIF/56066-63-8.gif) |
5-[(4-??????-3,5-????-??)??]????-2,4-??? |
56066-63-8 |
C15H21N5O2 |
 |
???????I,?????? |
1135688-15-1 |
C30H49FN6O8S |
 |
5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-α-L-manno-2-nonulopyranosonic acid methyl ester 2,4,7,8,9-pentaacetate |
117405-58-0 |
C22H30FNO14 |
 |
ICG-Polylysine |
|
|
 |
PLA2G2A |
|
|
 |
PRN-1008 |
1575591-66-0 |
C36H40FN9O3 |
 |
guanosine cyclic 2',3'-(hydrogen phosphate) |
634-02-6 |
C10H12N5O7P |
 |
TYRP1 |
|
|
 |
Txa2 receptor |
|
|
 |
Epithelial Na channel β subunit |
|
|
 |
HIV-1 GAG P24 ANTIGEN |
|
|
 |
PCCB |
|
|
 |
PDCD1LG2 |
|
|
 |
PGAM1 |
|
|
 |
PGRPS |
|
|
 |
ERK1/2 inhibitor 1 |
2095719-90-5 |
C29H32ClN5O4 |
![(S)-3-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecyl)oxy)propane-1,2-diol](/CAS/20240320/GIF/154371-96-7.gif) |
(S)-3-((12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecyl)oxy)propane-1,2-diol |
154371-96-7 |
C21H34N4O6 |
![4-HYDROXY-2-[(1E)-[4-(1-METHYLETHYL)PHENYL]METHYLENE]HYDRAZIDE](/CAS/GIF/101574-65-6.gif) |
4-HYDROXY-2-[(1E)-[4-(1-METHYLETHYL)PHENYL]METHYLENE]HYDRAZIDE |
101574-65-6 |
C17H18N2O2 |
 |
bPiDDB |
525596-66-1 |
C24H38Br2N2 |
 |
????S-??????? |
3724-89-8 |
C2H9NNaO3PS |
 |
GingerPowder |
|
|
 |
NA |
367275-82-9 |
C24H27NO4 |
 |
FAPI-4 |
2374782-02-0 |
C40H54F2N10O10 |
 |
((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl)-L-serine |
132173-31-0 |
C23H35NO4 |
 |
Methyltetrazine-Maleimide |
|
|
 |
Tara tannin |
|
|
 |
CY5-Catalase |
|
|
 |
????Q9 |
303-97-9 |
C54H82O4 |
 |
PIWIL4 |
|
|
 |
PITX2 |
|
|
 |
Prospero homeobox protein 1 |
|
|
 |
Remibrutinib |
1787294-07-8 |
C27H27F2N5O3 |
 |
Highly flexible epoxy resin |
|
|
 |
2,2',2''-(2-(4-(3-(1-(4-(1,2,4,5-tetrazin-3-yl)phenyl)-3,6-dioxo-10,13,16-trioxa-2,7-diazaoctadecan-18-yl)thioureido)benzyl)-1,4,7-triazonane-1,4,7-triyl)triacetic acid |
2683067-77-6 |
C41H57N11O11S |
 |
NB-598 |
131060-14-5 |
C27H31NOS2 |
 |
PELO |
|
|
 |
KP-302 |
2082765-42-0 |
C20H23N5O2 |
 |
CarbaMicacid,N,N'-1,2-??????-,C,C'-??(1,1-?????)???? |
33105-93-0 |
C12H24N2O4 |
 |
TNNT1 |
|
|
 |
Cyclocarya paliurus |
|
|
 |
FITC-Catalase |
|
|
 |
Protonex? Red 780, NHS ester |
|
|
 |
Bromocresol purple indicator solutionc(C21H16Br2O5S)=1 g/L |
|
|
![7-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride](/CAS/20150408/GIF/1588441-26-2.gif) |
7-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride |
1588441-26-2 |
C8H18Cl2N2 |
 |
PLCD3 |
|
|
 |
Plexin B2 |
|
|
 |
(S)-1-methoxy-N,3-dimethylbutan-2-amine |
113336-62-2 |
C7H17NO |
 |
Fmoc-D-2-Me-Trp |
196808-79-4 |
C27H24N2O4 |
![4H-Pyrazolo[1,5-a][1,4]diazepine-2-carboxamide, 5-[(7S)-7-[3-amino-2-fluoro-5-(1-propyn-1-yl)-6-(trifluoromethyl)phenyl]-7,8-dihydro-2-[[(7aS)-tetrahydro-2-methylene-1H-pyrrolizin-7a(5H)-yl]methoxy]-5H-pyrano[4,3-d]pyrimidin-4-yl]-3-chloro-5,6,7,8-tetrahydro-N,N-dimethyl-](/CAS/20240320/GIF/3024878-19-8.gif) |
4H-Pyrazolo[1,5-a][1,4]diazepine-2-carboxamide, 5-[(7S)-7-[3-amino-2-fluoro-5-(1-propyn-1-yl)-6-(trifluoromethyl)phenyl]-7,8-dihydro-2-[[(7aS)-tetrahydro-2-methylene-1H-pyrrolizin-7a(5H)-yl]methoxy]-5H-pyrano[4,3-d]pyrimidin-4-yl]-3-chloro-5,6,7,8-tetrahydro-N,N-dimethyl- |
3024878-19-8 |
C36H39ClF4N8O3 |
 |
ICG-Tetrazine |
|
|
 |
PLTP |
|
|
 |
E)-1-(4-Hydroxy-phenyl)-3-(2,4,6-trimethoxy-phenyl)-propenone |
1389310-69-3 |
C18H18O5 |
 |
Brentuximab |
2088770-90-3 |
|
 |
??????? |
1553-56-6 |
C24H38O3 |
 |
(R)-2-??????????? |
1910-47-0 |
C4H8O3 |
 |
IL-1 beta Recombinant Human mAb (S-2872-1) |
|
|
 |
Recombinant KexII Protease |
|
|
 |
(S)-2-AMINO-3-(5-FLUORO-1H-INDOL-3-YL)-PROPIONIC ACID |
16626-02-1 |
C11H11FN2O2 |
 |
Cytochrome P450 Monooxygenase |
|
|
 |
Disitamab |
2185868-98-6 |
|
 |
KB-0742 |
2416873-83-9 |
C16H25N5 |
 |
P4030-01 pH Buffers Solutions-25℃ |
|
|
 |
Mouse IL-2 Recombinant mAb (S-3077-2) |
|
|
 |
11-Anhydro-16-oxoalisol A |
156338-93-1 |
C30H46O5 |
 |
BI-3406 |
2230836-55-0 |
C23H25F3N4O3 |
 |
Afamelanotide acetate |
1566590-77-9 |
C80H115N21O21 |
 |
306Oi9-cis2 |
3027930-39-5 |
C55H99N3O8 |
 |
CD4 Nanobeads, human (RUO) |
|
|
 |
ANTIBODY DILUENT |
|
|
 |
?????? |
9001-47-2 |
|
 |
GNF362 |
1003019-41-7 |
C22H21F3N6 |
 |
Rabbit Anti-HA tag agarose beads |
|
|
 |
TAT(48-59) |
|
|
 |
(E,Z)-2,13-???????????? |
86252-65-5 |
C20H36O2 |
 |
Common Cnidium Fruit Extract |
|
|
 |
Lily Extract |
|
|
 |
??-9,???-12-???????-1-? ???? |
31654-77-0 |
C16H28O2 |
 |
IL-6 Mouse mAb (S-1038-139) |
|
|
 |
Jasmine tea powder |
|
|
 |
Stomach organoids Cytokine Set, Human |
|
|
 |
Saroglitazar (Magnesium) |
1639792-20-3 |
C50H56MgN2O8S2 |
 |
bimekizumab |
1418205-77-2 |
|
 |
OOLONG TEA EXTRACT |
|
|
 |
XYLOOLIGOSACCHARIDE |
|
|
 |
Mal-PEG8-Phe-Lys-PAB-Exatecan |
2679821-44-2 |
|
 |
CD3 Nanobeads, human (RUO) |
|
|
 |
Z-GLU(OME)-OH |
4652-65-7 |
C14H17NO6 |
![L-Phenylalanine, N-[6-(3,4-dibromo-2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-N-methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-](/CAS/20211123/GIF/1810001-93-4.gif) |
L-Phenylalanine, N-[6-(3,4-dibromo-2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-N-methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl- |
1810001-93-4 |
C49H74Br2N6O11 |
 |
FD-1080 NH2 |
|
|
 |
RT-RPA 4.0 Nucleic Acid Amplification Reagent (Basic Type) |
|
|
 |
Sacituzumab |
1796566-95-4 |
|
 |
6-???-1,7-?????-8H-??-8-?? |
7390-62-7 |
C5H5N5S |
 |
???S |
1149-99-1 |
C15H20O4 |
 |
Eloralintide |
2883634-40-8 |
|
 |
Mouse IL-2 Recombinant mAb (S-3077) |
|
|
 |
Mitofilin Recombinant Rabbit mAb (S-2277-37) |
|
|
 |
FMoc-5-????-L-???? |
908846-88-8 |
C26H21FN2O4 |
 |
Donanemab |
1931944-80-7 |
|